Magna International: BMO Lowers Estimates On Lower Production Expectations

On August 16 BMO Capital Markets slightly lowered their 12-month price target on Magna International (TSX: MG) while reiterating their outperform rating. They say the reason for the price target change is due to revising their third quarter earnings per share estimate to $1.47 from $1.63.

Magna International has 10 analysts covering the stock, with 1 having a strong buy rating, 8 have buy ratings and 1 analyst has a hold rating. The consensus 12-month price target sits at $111 while the street high comes in at $129.45 and the lowest is $88.

With the chip shortage still heavily in effect, BMO has lowered its expectations around production. They say that the West Detroit Three production is now expected to increase 31% sequentially, lower than their original 50% estimate. The companies revenue meanwhile is expected to grow 14%, underperforming its production increase.

The company’s western production is expected to decrease 4.5% sequentially, which is 1% weaker than their original estimate. Revenues from Magna’s European platforms are estimated to decrease 5.5% sequentially. This is primarily due to the companies top platforms, the BMW 1-Series and Volkswagen Tiguan, both expected to drop 22% sequentially.

Below you can see BMO’s updated third quarter, full year 2021, and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Silver Needs to Slow Down to Go Higher | Dan Dickson – Endeavour Silver

Silver Dips Are Getting Bought, This Is How Breakouts Start | John Feneck

Why $100 Silver Right Now Would Be a Problem | Keith Neumeyer – First Majestic

Recommended

Antimony Resources Planning 10,000 Metre Drill Program For H1 2026

Canadian Copper Closes On Sale Of Turgeon Project In New Brunswick For Cash And Shares

Related News

Medipharm Labs: Canaccord Drops Target To Just $0.10

On May 16, Medipharm Labs (TSX: LABS) reported its first quarter financial results. The company...

Tuesday, May 24, 2022, 11:37:00 AM

Taiga Motors: Canaccord Initiates Coverage With $23 Price Target

Canaccord recently intiated coverage on Taiga Motors (TSX: TAIG), a recently de-SPAC’d company with a...

Saturday, May 8, 2021, 12:07:00 PM

Aritzia Sees Consensus Price Target Rise After Q2 Results

Aritzia (TSX: ATZ) last week reported its second quarter results for fiscal 2023, for the...

Wednesday, October 19, 2022, 12:44:00 PM

Medipharm Labs: Canaccord Lowers Targets After Earnings

On August 16, Medipharm Labs (TSX: LABS) reported their second quarter financial results. The company...

Friday, August 20, 2021, 07:54:00 AM

Nike: BMO Lowers Price Target To $170 Following Q1 Results

Earlier this week, Nike Inc (NYSE: NIKE) reported its fiscal first quarter of 2022. The...

Friday, October 1, 2021, 04:45:00 PM